黄杨碱
分析标准品,T≥99%
Cyclovirobuxine
CAS号:860-79-7
分子式:C26H46N2O
分子量:402.66
MDL:MFCD00468040
货号 | 规格/参数/品牌 | 价格 | 货期 |
YJ-B20573-20mg | 分析标准品,T≥99% | ¥300.00 | 现货 |
JS31427-1g | ≥98% | ¥924.00 | 现货 |
JS31427-5g | ≥98% | ¥2324.00 | 现货 |
JS31427-25g | ≥98% | ¥5550.00 | 2-3天 |
JS31427-100g | ≥98% | ¥13000.00 | 2-3天 |
产品介绍
熔点:218-220℃
沸点:495.7 ℃ at 760 mmHg
外观:无色针状结晶
溶解性:在氯仿中易溶,在甲醇或乙醇中溶解,在丙tong中略溶,在水中微溶。
储存条件:2-8℃
注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
参考文献(7篇)
7. [IF=10.7] Yingying Shao et al."Targeting LIF With Cyclovirobuxine D to Suppress Tumor Progression via LIF/p38MAPK/p62-Modulated Mitophagy in Hepatocellular Carcinoma."MedComm.2025 May;6(6):e70227
6. [IF=4.9] Yun-Hao Ren et al."Unlocking the Stratum Corneum Barrier to Skin Penetration for the Transdermal Delivery of Cyclovirobuxine D."Pharmaceutics.2024 Dec;16(12):1600
5. [IF=3.1] Gao Ke et al."Suppressing the progression of bladder cancer using cyclovirobuxine D based on network pharmacology and bioinformatics approaches."NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY.2025 Jan;:1-19
4. [IF=6.8] Yiman Liu et al."Repurposing cyclovirobuxine D as a novel inhibitor of colorectal cancer progression via modulating the CCT3/YAP axis."BRITISH JOURNAL OF PHARMACOLOGY.2024 Jul;:
3. [IF=5] Ke Gao et al."DNA repair pathways-targeted cyclovirobuxine inhibits castration-resistant prostate cancer growth by promoting cell apoptosis and cycle arrest."Translational Oncology.2023 Sep;35:101708
2. [IF=3.417] Lingqi Zhou et al."Cyclovirobuxine D inhibits cell proliferation and migration and induces apoptosis in human glioblastoma multiforme and low‑grade glioma."Oncol Rep. 2020 Mar;43(3):807-816
1. 增夏,关怀敏,王贺,邱承杰,赵亚楠,曹英杰,解金红.环维黄杨星D对H_2O_2损伤大鼠心房肌细胞L型钙通道的影响[J].广东医学,2020,41(16):1631-1636.
